Please assess the completion status of the following clinical trial:

Trial Title: Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of cystic fibrosis, made accordingly to the Cystic Fibrosis Foundation Guideline (Rosenstein BJ. J Pediatr 1998;132: 589-595)~* age of 18 years or more and ability to consciously express owns informed consent.~* have a prescription done by one of the CF Centre specialist Physicians of an IV antibiotic course of the expected duration of 2 weeks, due to a pulmonary exacerbation, with the association of ceftazidime 3 times daily and tobramycin once daily diluted in Normal Saline.~* absence of clinical conditions that contraindicate the administration of 350ml of Normal Saline in 30 minutes 3 times daily and of 400ml of Normal Saline in 40 minutes.~* no simultaneous anti-inflammatory therapy administered orally, IM or IV~* 30 days have passed from the end of the previous course.~* The IV course will be given to the subject as an inpatient, and he or she will be admitted to our hospital

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Higher concentration of antibiotic in NS
- B (Type: EXPERIMENTAL): Lower concentration of antibiotic in NS

Based on this trial design, predict the completion outcome and termination type (if applicable).